Peoples Financial Services CORP. Has $288,000 Stock Position in Danaher Corporation $DHR

Peoples Financial Services CORP. lowered its stake in Danaher Corporation (NYSE:DHR) by 35.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,456 shares of the conglomerate’s stock after selling 786 shares during the period. Peoples Financial Services CORP.’s holdings in Danaher were worth $288,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Summit Global Investments boosted its position in Danaher by 18.0% in the first quarter. Summit Global Investments now owns 1,057 shares of the conglomerate’s stock valued at $217,000 after buying an additional 161 shares in the last quarter. Peoples Bank KS boosted its position in Danaher by 6.4% in the first quarter. Peoples Bank KS now owns 1,910 shares of the conglomerate’s stock valued at $392,000 after buying an additional 115 shares in the last quarter. Mechanics Bank Trust Department boosted its position in Danaher by 3.0% in the first quarter. Mechanics Bank Trust Department now owns 9,507 shares of the conglomerate’s stock valued at $1,949,000 after buying an additional 274 shares in the last quarter. JGP Wealth Management LLC boosted its position in Danaher by 5.3% in the first quarter. JGP Wealth Management LLC now owns 3,852 shares of the conglomerate’s stock valued at $790,000 after buying an additional 194 shares in the last quarter. Finally, Czech National Bank boosted its position in Danaher by 5.4% in the first quarter. Czech National Bank now owns 146,962 shares of the conglomerate’s stock valued at $30,127,000 after buying an additional 7,584 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $184.97 on Monday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.59. The firm has a fifty day simple moving average of $199.44 and a 200 day simple moving average of $197.48. The company has a market capitalization of $132.45 billion, a PE ratio of 39.36, a P/E/G ratio of 2.63 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analyst Ratings Changes

A number of analysts have weighed in on DHR shares. Deutsche Bank Aktiengesellschaft cut their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Barclays reaffirmed an “overweight” rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Robert W. Baird raised their price target on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Finally, Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research note on Tuesday, September 2nd. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $245.91.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 11.20% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.